Lately, one of America's leading pharmaceutical companies can't catch a break from Wall Street. Shares of Vertex ...

Vertex Pharmaceuticals (NASDAQ: VRTX) just snagged its second U.S. Food and Drug Administration (FDA) approval in only 41 ...

This disruption to Germany’s position as the leader in pharmaceuticals ... as the century progresses. Vertex's gene-editing therapy for sickle cell disease, Casgevy, has been given the nod ...

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.